Jnj competitors.

J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.Competitive benchmarking is a useful tool for understanding where you can go next with your , and to see where you could be servicing your customers more effectively. It can help you see why your audience might choose a competitor over you, and work on strategies to attract them to your offering instead.Analysis of Johnson & Johnson 2021. Johnson & Johnson is a famous multinational corporation that manufactures and markets pharmaceuticals, medical devices, and consumer packaged goods. The company's core focus is to develop products related to human health and well-being. In this effort, the company, through its subsidiaries, operates over 120 ...Johnson & Johnson - Company Profile. Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Johnson & Johnson stacks up to the competition and put relevant competitor and industry information at your fingertips. JNJ Sales vs. its Competitors Q3 2023. Comparing the current results to its competitors, Johnson And Johnson reported Revenue decrease in the 3 quarter 2023 year on year by -10.26 %, despite the revenue increase by most of its competitors of 4.83 %, recorded in the same quarter. • List of JNJ Competitors.

Johnson & Johnson's main competitors include Unilever, Abbott, GSK, Medtronic, Novartis, Pfizer, Procter & Gamble, Roche and Bayer. Compare Johnson & Johnson to its competitors by revenue, employee growth and other metrics at Craft.JNJ Profile >> Back to JNJ Fundamentals >> Compare JNJ Financial Strength to its Competitors Note To view Detail Information & Trends click on Individual Category.

A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 2, 2011. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson.Johnson & Johnson Competitors. Country Company Market Cap ROCE US Johnson & Johnson. NYSE:JNJ 353B USD: 21% JP N Nichi-Iko Pharmaceutical Co Ltd. TSE:4541 ...

New Brunswick, N.J. (May 22, 2014) – At a meeting today with members of the investment community, senior leaders from the Medical Devices and Diagnostics (MD&D) segment of Johnson & Johnson will outline plans to improve patient outcomes and expand their market leadership through innovative products, new business models and a …Johnson & Johnson pays an annual dividend of $4.76 per share and has a dividend yield of 3.0%. Eli Lilly and Company pays an annual dividend of $4.52 per share and has a dividend yield of 0.8%. Johnson & Johnson pays out 35.3% of its earnings in the form of a dividend.Lastly, it’s important to evaluate a stock by comparing it against others in the same industry. Review the table below to see how Johnson & Johnson stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions. Johnson & Johnson (JNJ) CompetitorsDec 1, 2023 · This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment ...

... JNJ and is also a component of the Dow Jones Industrial Average (DJIA). Competition and Market Share. As a healthcare conglomerate, Johnson & Johnson ...

The increase in CD8+ T-cells generated by the Johnson & Johnson vaccine may be key to explaining the high levels of effectiveness against severe COVID-19 disease and hospitalization. Additional Information The Johnson & Johnson COVID-19 vaccine has been authorized as a booster by multiple regulators and healthcare bodies around the world.

JNJ Sales vs. its Competitors Q3 2017. Comparing the results to its competitors, Johnson & Johnson reported Total Revenue increase in the 3 quarter 2017 by 10 % year on year. The sales growth was above …Economic indicators with impact on Johnson And Johnson's sales, demand side and costs, supply side - CSIMarketCompetitors. Sanofi-Aventis , ... Johnson & Johnson should be over the setbacks caused by its former CEO and the string of recalls it was made to handle. Now is the real test. Investors should ...The latest price target for Johnson & Johnson ( NYSE: JNJ) was reported by RBC Capital on Friday, December 1, 2023. The analyst firm set a price target for 178.00 expecting JNJ to rise to within ...JNJ Operating Income third quarter 2023 Y/Y Growth Comment: Johnson And Johnson reported decrease in Operating Income in the third quarter 2023 by -7.66% to $ 5,740.00 millions, from the same quarter in 2022. The decrease in the third quarter 2023 Johnson And Johnson's Operating Income compares unfavorably to the Company's average Operating …The Top 7 Johnson & Johnson Competitors: Pfizer, Merck, GlaxoSmithKline, Bayer, Abbott, Bristol Myers Squibb, Medtronic. Together, including the revenue of J&J, they contribute nearly $342 billion in annual revenues to the medical sector. Their total employee count is close to 730,000.Johnson And Johnson's Revenue per employee fell on a trailing twelve month basis to $ 672,781, but the productivity of Johnson And Johnson's employees remained above the company average. Within the Healthcare sector Employees of 8 other companies have achieved higher revenue per employee. While revenue/employee total ranking has …

Johnson & Johnson Ranks 5th in Net Promoter Score. 931 Customers rate Johnson & Johnson's Net Promoter Score a 26, which ranks it 5th against its competitors, below Procter & Gamble. Net Promoter score tracks customers' overall score to this question - “On a scale from 0-10, how likely are you to recommend Johnson & Johnson to a friend?”. Johnson And Johnson's inventory turnover ratio, the ratio that measures Johnson And Johnson's ability to manage its supply chain, sequentially decreased to 2.51 in the third quarter 2023, which does not come as a surprise, as the Johnson And Johnson continue to experience headwinds, which also impact its supply chain. Johnson And Johnson's …Johnson & Johnson (JNJ 1.68%) is a well-known consumer and healthcare company that has been in operation for more than a century. Meanwhile, Intuitive Surgical ( ISRG 0.03% ) has made a name for ...When it comes to searching for a new home, the online platform you choose can make all the difference. One of the key factors that set Rightmove apart from its competitors is its extensive database of property listings.The average twelve-month price prediction for Johnson & Johnson is $169.19 with a high price target of $215.00 and a low price target of $52.00. Learn more on JNJ's analyst rating history. Do Wall Street analysts like Johnson & Johnson more than its competitors?GlobalData’s report assesses how JNJ-8114’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication ... You can make better informed decisions and gain a future-proof advantage over your competitors. Be better informed. GlobalData, the leading provider of industry intelligence, provided ...Competitors. Sanofi-Aventis , ... Johnson & Johnson should be over the setbacks caused by its former CEO and the string of recalls it was made to handle. Now is the real test. Investors should ...

View All Zacks #1 Ranked Stocks Johnson & Johnson (JNJ) Quote …A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 2, 2011. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson.

A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 2, 2011. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson.Apr 19, 2023 ... Johnson & Johnson $JNJ Q1 2023 Earnings Call Listen to the latest conference call between the company and financial analysts or investors as ...J&J Says They Made a Deal with ARC in 1895 (Score: 5, Informative) Johnson & Johnson on Wednesday sued the American Red Cross over the use by the relief group and its partners of J&J's trademark red cross logo on first aid kits, hand sanitizer and medical gloves sold to the public.McNeil Consumer Healthcare, the JNJ subsidiary that markets Tylenol, was responsible for $2.1 billion of company's overall $47 billion in 2004 sales. Therefore, analysts don't expect a sales drop ...Commenting Third Quarter 2023 EBITDA Margin: Johnson and Johnson experienced contraction in EBITDA by -19.95 % to $ 21,351 millions and Revenue by -16.37 %, while EBITDA Margin fell to 33.9 %, above company's average EBITDA Margin. Observing third quarter 2023 results within Major Pharmaceutical Preparations industry 32 other …Effective Tax Rate Comment: On the trailing twelve months basis Company's effective tax rate in III. Quarter decreased compare to previous quarter to 16.43 %, below company's average Effective Tax Rate. Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Effective Tax Rate. While total ranking remained …JNJ Profile >> Back to JNJ Fundamentals >> Compare JNJ Financial Strength to its Competitors Note To view Detail Information & Trends click on Individual Category.F. Hoffmann-La Roche Ltd: Overview. F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides medicines for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases.J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.

Johnson And Johnson's current Dividend, dividend pay out and yield comparisons to industry, sector, and S&P 500

When it comes to luxury private jets, the Gulfstream G650 is often regarded as one of the best in its class. With its sleek design, advanced technology, and exceptional performance capabilities, this aircraft stands out from its competitors...

Find real-time JNJ - Johnson & Johnson stock quotes, company profile, news and forecasts from CNN Business. ... Competitors; vs. Health Technology. News. Chart. Latest JNJ News | Press Releases ...Here is an in-depth analysis of top Johnson & Johnson’s competitors and alternatives: Table of Contents 1. Pfizer 2. Novartis International AG 3. Merck & Co 4. GlaxoSmithKline (GSK) 5. Bayer 6. Procter & Gamble Co (P&G) 7. Medtronic 8. Abbott Laboratories 9. AbbVie 10. Bristol Myers Squibb (BMS) 11.Find useful insights on Johnson & Johnson’s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Johnson & Johnson.Mar 29, 2023 · Johnson & Johnson on Wednesday said it’s ducking out of the vaccine race for the respiratory syncytial virus, known as RSV, weeks after competitors Pfizer and GSK inched closer to launching the ... This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment ...With the rise of e-commerce, more and more customers are turning to online shopping for their everyday needs. When it comes to home improvement and building supplies, Menards is a popular choice for many.Johnson & Johnson researches, develops, manufactures, and sells products in health care. The company was founded by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, in New Brunswick, New Jersey, in 1886 (J&J website). Alex Gorsky is currently the chairman and chief executive officer of the company.Jun 19, 2019 · Johnson & Johnson’s (NYSE:JNJ) consumer healthcare revenue could grow at a CAGR of 1.6% from $13.8 billion in 2018 to $14.5 billion in 2021, according to Trefis estimates. This growth will ... JNJ competitors include Novartis AG ADR , Merck & Co Inc and Pfizer Inc . The table below presents a comparison based on important metrics. JNJ. NVS. MRK. PFE. P/E. 24.30. 17.40.Apr 19, 2022 · April 19, 2022. New Brunswick, N.J. (April 19, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2022. “Our first quarter results demonstrate strong performance across the enterprise, despite macro-economic headwinds. I am incredibly proud of Johnson & Johnson ’s 144,000 employees for their relentless passion ... Dec 31, 2022 · Comparison Analysis Based on SEC Data. Company Name. Johnson & Johnson. Industry (SIC) 2834 - Pharmaceutical Preparations. Revenue in 2022. $94,943 million (ranked #2 out of 645 companies in the industry) Assets as of 12/31/2022. $187,378 million (ranked #2)

Here is the SWOT analysis for Johnson & Johnson (J&J) A SWOT analysis is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats of a business, project, or individual. It involves identifying the internal and external factors that can affect a venture’s success or failure and analyzing them to develop ...Jun 16, 2022 · Johnson & Johnson Or Novo Nordisk: Which Is The Best Big Pharma Near Cap-Gainer Jun. 16, 2022 5:35 AM ET Johnson & Johnson (JNJ) NVO 11 Comments 9 Likes Peter F. Way, CFA Dec 1, 2023 · In the previous week, Eli Lilly and Company had 11 more articles in the media than Novo Nordisk A/S. MarketBeat recorded 37 mentions for Eli Lilly and Company and 26 mentions for Novo Nordisk A/S. Eli Lilly and Company's average media sentiment score of 0.71 beat Novo Nordisk A/S's score of 0.20 indicating that Eli Lilly and Company is being referred to more favorably in the news media. Instagram:https://instagram. real estate vs mutual fundsppg pricehow to get a margin account on webullwhere can you sell xbox 360 A new service from Walmart named ShippingPass will offer 3-day shipping and cost $50 per year. That's half the price of Amazon Prime. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I agree t... crowdfunding real estatemobile stock trading apps Johnson & Johnson Ranks 5th in Net Promoter Score. 931 Customers rate Johnson & Johnson's Net Promoter Score a 26, which ranks it 5th against its competitors, below Procter & Gamble. Net Promoter score tracks customers' overall score to this question - “On a scale from 0-10, how likely are you to recommend Johnson & Johnson to a friend?”. utility dividend stocks The main competitors of Bristol-Myers Squibb include Pfizer (PFE), AbbVie (ABBV), Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Sanofi (SNY), GSK (GSK), Takeda Pharmaceutical (TAK), and Abbott Laboratories (ABT). These companies are all part of the "pharmaceutical preparations ...Jan 7, 2023 · Click to enlarge (Source - SEC) Kenvue’s Market & Competition. According to a 2022 market research report by Research and Markets, the global market for consumer healthcare products was an ... Jan 31, 2022 · JNJ reported $82.58 billion in revenue for the 2020 fiscal year—$43.13 billion from the United States while the remaining $39.45 billion came from international sources. Johnson & Johnson ...